{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Parsippany",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "ANDA077686"
        ],
        "brand_name": [
          "MATZIM LA"
        ],
        "generic_name": [
          "DILTIAZEM HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Actavis Pharma, Inc."
        ],
        "product_ndc": [
          "52544-691",
          "52544-692",
          "52544-693",
          "52544-694",
          "52544-695"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DILTIAZEM HYDROCHLORIDE"
        ],
        "rxcui": [
          "830877",
          "830879",
          "830882",
          "830897",
          "830900",
          "1091623",
          "1091629",
          "1091632",
          "1091635",
          "1091638"
        ],
        "spl_id": [
          "6b586f35-6eb1-488c-839e-581f695d3f07"
        ],
        "spl_set_id": [
          "e8c8dd18-9d95-4068-9762-bec1eb1bc25c"
        ],
        "package_ndc": [
          "52544-691-30",
          "52544-691-19",
          "52544-691-10",
          "52544-692-30",
          "52544-692-19",
          "52544-692-10",
          "52544-693-30",
          "52544-693-19",
          "52544-693-10",
          "52544-694-30",
          "52544-694-19",
          "52544-694-10",
          "52544-695-30",
          "52544-695-19",
          "52544-695-10"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "OLH94387TE"
        ]
      },
      "product_type": "Drugs",
      "event_id": "83730",
      "recalling_firm": "Teva Pharmaceuticals USA",
      "address_1": "400 Interpace Pkwy",
      "address_2": "N/A",
      "postal_code": "07054-1120",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.",
      "recall_number": "D-0131-2020",
      "product_description": "Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ  NDC 52544-692-30",
      "product_quantity": "5,849 bottles",
      "reason_for_recall": "GMP Deviation: lot not intended for commercial distribution.",
      "recall_initiation_date": "20190906",
      "center_classification_date": "20191009",
      "termination_date": "20200519",
      "report_date": "20191016",
      "code_info": "Lot # 1344864A, exp. date 10/2020"
    }
  ]
}